“When it turns out that some people do not really respond to vaccines, which is to be expected with all vaccines, there was an initiative to approach these people and give them a third dose of Sinopharm vaccine, which was shown, in the course of a study, to boost their immunity,” he said. A person with low levels of antibodies after the test can ask their doctor to contact the health authorities and will be scheduled for another dose, although generally those responsible are the ones who approach the person. He likened the need for the third vaccine as a booster for influenza, and said that those who needed it were “a very small number”. The health sector spokeswoman, Farida Al Hosani, told the National newspaper that the need for a third injection on March 10, and according to doctors reported by The Wall Street Journal, there have been cases of people with little or no suffering. The antibody response after two doses of Synopharma, the discoveries could raise doubts about the effectiveness of the Sinopharm vaccine, which is widely used around the world as countries scramble to find vaccines. Many of the most effective Western vaccines have been purchased by wealthier countries, and Sinopharm has a self-reported efficacy rate of 79% – which global health experts say is more than enough – but its data has not been made public. In addition to the UAE, the vaccine was purchased by countries such as Egypt, Cambodia, Senegal, and Peru, and the UAE was characterized by a robust vaccination program that initially used Sinopharma, which also conducted phase III trials in the country, and was later expanded to include Pfizer-BioNTech and AstraZeneca. And Russia’s Sputnik V, according to ads on Saturday, nearly 73 percent of the elderly population has received at least one vaccine dose. That number drops to 56% for all eligible adults, and the government also announced that as of Sunday, everyone in the country is now eligible to receive a vaccine, after restricting injections to people with special needs over the past six weeks. The highest national vaccination rate is in the region with more than 7 million doses administered to a population of only 9 million. The vaccine is free for all citizens and residents, and the number of new daily cases quadrupled to nearly 4,000 in January, and only now has it decreased to about 2,000 new cases per day.